Your browser doesn't support javascript.
loading
S1PR2/Wnt3a/RhoA/ROCK1/ß-catenin signaling pathway promotes diabetic nephropathy by inducting endothelial mesenchymal transition and impairing endothelial barrier function.
Zhang, Jing; Chen, Shuhua; Xiang, Hong; Xiao, Jie; Zhao, Shaoli; Shu, Zhihao; Chai, Yanfei; Ouyang, Jie; Liu, Huiqin; Wang, Xueweng; Quan, Qisheng; Fan, Jianing; Gao, Peng; Chen, Alex F; Lu, Hongwei.
Afiliación
  • Zhang J; Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, China; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Chen S; Department of Biochemistry, School of Life Sciences of Central South University, Changsha, China.
  • Xiang H; Center for Experimental Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Xiao J; Department of Emergency, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Zhao S; Department of Endocrinology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Shu Z; Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, China; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Chai Y; Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, China; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Ouyang J; Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, China; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Liu H; Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, China; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Wang X; Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, China; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Quan Q; Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, China; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Fan J; Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, China; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Gao P; Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, China; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Chen AF; Institute for Cardiovascular Development and Regenerative Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Lu H; Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, China; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, China; Center for Experimental Medicine, The Third Xiangya Hospital of Central South University, Changsha, Ch
Life Sci ; 328: 121853, 2023 Sep 01.
Article en En | MEDLINE | ID: mdl-37307963

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus / Nefropatías Diabéticas Límite: Animals / Humans Idioma: En Revista: Life Sci Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus / Nefropatías Diabéticas Límite: Animals / Humans Idioma: En Revista: Life Sci Año: 2023 Tipo del documento: Article País de afiliación: China